USPTO Examiner LUARCA MARGARET M - Art Unit 3785

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18784481NOISE-REDUCING AIR PASSAGE DEVICE AND ITS COMPONENTS FOR USE IN VENTILATOR SYSTEMSJuly 2024February 2025Allow710NoNo
18640563METHOD AND SYSTEM FOR TREATING CENTRAL SLEEP APNEAApril 2024June 2024Allow210NoNo
18429915NASOPHARYNGEAL AIRWAY SYSTEM DEVICEFebruary 2024November 2024Allow910NoNo
18525346AUTOMATIC RESCUE BREATHING UNIT WITH KEYING SYSTEMNovember 2023August 2024Allow900NoNo
18385990SYSTEMS AND METHODS FOR MONITORING THE RESPIRATORY STATUS OF A USERNovember 2023June 2024Allow810NoNo
18486447AEROSOL-GENERATING SYSTEM INCLUDING A CARTRIDGE CONTAINING A GELOctober 2023March 2025Allow1700NoNo
18353328LINER FOR A RESPIRATOR MASKJuly 2023April 2025Allow2110NoNo
18217771METHOD AND SYSTEM FOR TREATING CENTRAL SLEEP APNEAJuly 2023March 2024Allow810NoNo
18257096SYSTEMS AND METHODS FOR DETECTING RAINOUT IN A RESPIRATORY THERAPY SYSTEMJune 2023January 2024Allow700YesNo
18315645HFNC SYSTEMMay 2023August 2023Allow400YesNo
18185396Atomizer with intelligent control digital display functionMarch 2023August 2023Allow510NoNo
18174263CONFORMING NASAL PILLOWFebruary 2023January 2025Allow2310NoNo
18022219Devices and Methods for Delivering Air to a PatientFebruary 2023November 2023Allow910NoNo
18018441SEAL-FORMING STRUCTURE OF PATIENT INTERFACE WITH MULTIPLE SEALING MATERIALSJanuary 2023November 2023Allow900NoNo
18084113SYSTEMS AND METHODS FOR MANUFACTURING AND SAFETY OF AN NO2-TO-NO REACTOR CARTRIDGE USED TO DELIVER NO FOR INHALATION THERAPY TO A PATIENTDecember 2022November 2024Allow2300NoNo
18000746SYSTEMS AND METHODS FOR IDENTIFYING A USER INTERFACEDecember 2022August 2023Allow910YesNo
18057145SYSTEMS AND METHODS FOR BREATH DETECTIONNovember 2022August 2024Abandon2121YesNo
17986352AEROSOL GENERATING DEVICE WITH PIERCING ASSEMBLYNovember 2022December 2024Allow2510NoNo
17966569MASK WITH VENT COLUMNSOctober 2022August 2023Allow1010YesNo
17963044SYSTEMS AND METHODS FOR SYNTHESIS OF NITRIC OXIDEOctober 2022April 2025Allow3010NoNo
17937741PATIENT INTERFACE DEVICEOctober 2022May 2025Allow3210YesNo
17933217ORAL GAS CATHETER AND METHOD OF INDUCING GAS IN A PATIENTSeptember 2022August 2023Allow1010YesNo
17911249RESPIRATOR DESIGNED TO MITIGATE DEEP LUNG INFECTIONSSeptember 2022April 2024Allow1921YesNo
17929808SYSTEMS AND METHODS FOR RESPIRATORY EFFORT DETECTION UTILIZING SIGNAL DISTORTIONSeptember 2022January 2025Abandon2910NoNo
17902260ATOMIZER WITH INTELLIGENT CONTROL DIGITAL DISPLAY FUNCTIONSeptember 2022July 2023Abandon1010NoNo
17879868ULTRASONIC WELDING OF FABRICS FOR SLEEP APNEA TREATMENTAugust 2022April 2025Allow3320NoNo
17865491COMPACT FLUID MOVING ASSEMBLY AND DEVICE EMPLOYING SAMEJuly 2022August 2024Allow2510NoNo
17848765BREATHING ASSISTANCE APPARATUSJune 2022August 2024Allow2500NoNo
17846550OUTLET CONNECTION ASSEMBLYJune 2022December 2022Allow610YesNo
17804629VENTILATOR WITH SWITCHING VALVEMay 2022December 2024Allow3010NoNo
17777927SECURITY TAGMay 2022April 2025Allow3510NoNo
17747052OUTLET CONNECTION ASSEMBLYMay 2022November 2022Allow610YesNo
17742347COMPONENT FOR CONVEYING GASESMay 2022November 2024Allow3010NoNo
17741081DUAL CONTAINER HYDROSTATIC VENTILATORMay 2022October 2022Allow510NoNo
17739002VENTILATION MASKMay 2022March 2025Abandon3410NoNo
17773499SYSTEMS AND METHODS FOR INSOMNIA SCREENING AND MANAGEMENTApril 2022September 2022Allow500NoNo
17660243Respiratory Pattern Analysis During Variable Positive Air Pressure Delivery For Spontaneously Breathing PatientsApril 2022March 2024Allow2331YesNo
17658321ADJUSTABLE FOREHEAD SUPPORT FOR A MASKApril 2022May 2025Allow3710NoNo
17714063MODULAR POWERED AIR PURIFYING RESPIRATOR SYSTEMApril 2022January 2025Allow3410NoNo
17708066CONTROL FOR PRESSURE OF A PATIENT INTERFACEMarch 2022June 2025Allow3910NoNo
17682222NASAL MASK SYSTEMFebruary 2022March 2025Allow3610NoNo
17674067INHALATION METHOD WITH CONTROLLED CYCLIC ACTIVATIONFebruary 2022July 2024Allow2910NoNo
17583666INHALATION DEVICE WITH INTEGRATED ELECTRONICSJanuary 2022February 2025Allow3610NoNo
17623549TUBE DETECTION SYSTEMS AND METHODSDecember 2021April 2025Allow3910NoNo
17620348DEVICE FOR REGULATING OXYGEN FOR AUTOMATED OXYGEN THERAPYDecember 2021November 2024Allow3500NoNo
17551444TWO-WAY COMMUNICATIONS IN A MEDICAL DEVICEDecember 2021June 2022Allow610NoNo
17539303BLOWERDecember 2021May 2024Allow3000NoNo
17539758PRODUCT DELIVERY DEVICES AND METHODSDecember 2021October 2022Allow1011NoNo
17537557NASAL ASSEMBLYNovember 2021August 2022Allow910YesNo
17537169BAG AND VALVE FOR ADVANCED RESPIRATORY SUPPORTNovember 2021April 2022Allow410NoNo
17533495RESPIRATORY ASSEMBLYNovember 2021September 2023Allow2210NoNo
17521700Robotic Ventilation Method Configured for Automatic Gas DeliveryNovember 2021January 2025Allow3810YesNo
17518996OUTLET CONNECTION ASSEMBLYNovember 2021August 2022Allow1021YesNo
17515305ELECTRONIC VAPING DEVICE WITH FLOATING ATOMIZEROctober 2021September 2024Abandon3520NoNo
17512549AIR-DELIVERY SYSTEM FOR BREATHING-ASSIST DEVICESOctober 2021January 2024Allow2710NoNo
17599420PATIENT INTERFACESeptember 2021February 2023Allow1720YesNo
17411711GAS WASHOUT VENT FOR PATIENT INTERFACEAugust 2021August 2024Allow3610NoNo
17445423RESPIRATOR DEVICES WITH SOURCE CONTROL MECHANISMS AND ASSOCIATED SYSTEMS AND METHODSAugust 2021January 2024Abandon2910NoNo
17444709SUPPORT FOR A BREATHING ASSISTANCE APPARATUS AND/OR ACCESSORIESAugust 2021December 2024Allow4020NoNo
17358221CRADLE CUSHION HAVING SIDE STABILIZERSJune 2021September 2023Allow2710NoNo
17304071PATIENT TUBE SECUREMENT APPARATUS FOR SECURING A PATIENT TUBE TO A PATIENTJune 2021April 2024Allow3420YesNo
17337706FACIAL INTERFACEJune 2021December 2023Abandon3010NoNo
17336682CAPNOXYGEN MASKSJune 2021December 2023Allow3020YesNo
17296273SECUREMENT DEVICE FOR A PROTRUDING ORAL OR NASAL DEVICEMay 2021June 2024Allow3710NoNo
17323266INHALER WITH ORIENTATION SENSORMay 2021June 2024Allow3710NoNo
17323824AEROSOL DELIVERY SYSTEMS AND RELATED METHODSMay 2021August 2024Allow3910NoNo
17316705DESIGN AND IMPLEMENTATION OF A LOW-COST BREATHING SUPPORT DEVICEMay 2021November 2021Allow610YesNo
17292667METHOD AND APPARATUS FOR CONTINUOUS MANAGEMENT OF AIRWAY PRESSURE FOR DETECTION AND/OR PREDICTION OF RESPIRATORY FAILUREMay 2021December 2022Allow1910NoNo
17316691Design and Implementation of a Low-Cost Breathing Support DeviceMay 2021April 2023Abandon2320NoYes
17238259PROTECTIVE EQUIPMENTApril 2021January 2022Abandon910NoNo
17234544APPARATUS AND METHOD FOR EARLY DETECTION OF VENTILATOR ASSOCIATED PNEUMONIAApril 2021October 2024Allow4210NoNo
17230206MASK APPARATUSApril 2021January 2024Allow3320NoNo
17223582Breathing Gas RemixerApril 2021October 2024Allow4211NoNo
17222718SYSTEMS AND METHODS FOR TREATING CORONAVIRUSApril 2021September 2023Allow2901NoNo
17220992NITRIC OXIDE ADMINISTRATION IN HIGH FREQUENCY OSCILLATORY VENTILATIONApril 2021December 2023Allow3310NoNo
17215589Sleep Apnea Nasal Pillows DeviceMarch 2021August 2024Allow4110NoNo
17213988FLUID TRAP APPARATUSMarch 2021June 2024Allow3910NoNo
17213007BAG AND VALVE FOR ADVANCED RESPIRATORY SUPPORTMarch 2021August 2021Allow510NoNo
17208442PORTABLE INHALATION THERAPEUTIC AND INHALATION AND EXHALATION MEASURING DEVICES AND RELATED METHODSMarch 2021May 2024Allow3830YesNo
17206732GAS FLOW REGULATING APPARATUS FOR RESPIRATORY TREATMENTMarch 2021August 2023Allow2910YesNo
17277208NITROUS OXIDE SEDATION ADMINISTRATION SYSTEMMarch 2021February 2022Abandon1110NoNo
17196117SYSTEMS AND METHODS FOR MANAGING MOISTURE FOR MEDICAL DEVICESMarch 2021July 2024Allow4010NoNo
17193934Oxygen Delivery PillowMarch 2021December 2021Allow1020YesNo
17193533OXYGEN-CAPNOGRAPHY MASK FOR CONTINUOUS CO2 MONITORINGMarch 2021August 2023Allow2910YesNo
17190912SYSTEM AND METHOD FOR DETECTING AGITATION, DISCOMFORT AND/OR SELF-EXTUBATION DURING INTUBATIONMarch 2021September 2023Allow3110NoNo
17186544RESUSCITATION SYSTEMFebruary 2021November 2024Allow4520NoNo
17178045GAS THERAPY SYSTEMFebruary 2021March 2025Allow4820YesNo
17164371Nozzles for Nasal Drug DeliveryFebruary 2021August 2023Allow3010YesNo
17155713BREATHING ASSISTANCE APPARATUS USER INTERFACEJanuary 2021May 2024Allow4010NoNo
17151059SYSTEMS AND METHODS FOR ENDOTRACHEAL DELIVERY OF FROZEN PARTICLESJanuary 2021November 2023Abandon3410NoNo
17257915ALTERATION-FREE GAS CONTROL DEVICE FOR A VENTILATORJanuary 2021December 2024Allow4710NoNo
17140457CONFIGURABLE OXYGEN CONCENTRATOR AND RELATED METHODJanuary 2021January 2024Allow3710YesNo
17138139INHALER DEVICE FOR INHALABLE LIQUIDSDecember 2020October 2023Abandon3410NoNo
17136737RESPIRATOR HAVING OPTICALLY ACTIVE EXHALATION VALVEDecember 2020June 2023Allow3020NoNo
17131870CUFF FOR AIR DELIVERY CONDUITDecember 2020November 2023Allow3510NoNo
17124805VIRTUAL RESPIRATORY GAS DELIVERY SYSTEMS AND CIRCUITSDecember 2020August 2023Allow3110NoNo
17120355OXYGEN SYSTEM FOR PARACHUTINGDecember 2020June 2025Abandon5411NoNo
17251323RESPIRATORY THERAPY DEVICES AND ASSEMBLIESDecember 2020May 2024Abandon4110NoNo
17112982FACEMASK HAVING INTEGRATED MODULESDecember 2020July 2021Allow810NoNo
17111997SYSTEM AND METHOD FOR MULTI-MODAL DOSING DEVICEDecember 2020November 2023Abandon3611NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner LUARCA, MARGARET M.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
2
Examiner Affirmed
1
(50.0%)
Examiner Reversed
1
(50.0%)
Reversal Percentile
79.2%
Higher than average

What This Means

With a 50.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
16
Allowed After Appeal Filing
6
(37.5%)
Not Allowed After Appeal Filing
10
(62.5%)
Filing Benefit Percentile
59.7%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 37.5% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner LUARCA, MARGARET M - Prosecution Strategy Guide

Executive Summary

Examiner LUARCA, MARGARET M works in Art Unit 3785 and has examined 340 patent applications in our dataset. With an allowance rate of 82.1%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 35 months.

Allowance Patterns

Examiner LUARCA, MARGARET M's allowance rate of 82.1% places them in the 47% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by LUARCA, MARGARET M receive 1.69 office actions before reaching final disposition. This places the examiner in the 48% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by LUARCA, MARGARET M is 35 months. This places the examiner in the 21% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +15.4% benefit to allowance rate for applications examined by LUARCA, MARGARET M. This interview benefit is in the 59% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 26.7% of applications are subsequently allowed. This success rate is in the 34% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 49.0% of cases where such amendments are filed. This entry rate is in the 68% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 150.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 89% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 81.8% of appeals filed. This is in the 72% percentile among all examiners. Of these withdrawals, 33.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 32.1% are granted (fully or in part). This grant rate is in the 25% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 43% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 42% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.